Evidence map›Paper›PMID 34248853›Full record

ReviewFrontiers in endocrinology2021

Update of Radiofrequency Ablation for Treating Benign and Malignant Thyroid Nodules. The Future Is Now.

Ralph P Tufano, Pia Pace-Asciak, Jonathon O Russell, Carlos Suárez, Gregory W Randolph, Fernando López, Ashok R Shaha, Antti Mäkitie, Juan P Rodrigo, Luiz Paulo Kowalski and 3 more

Open access · goldAbstract readHistorical ArticleReview
In one paragraph

Review in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Consensus Thyroid Nodule Radiofrequency Ablation Reporting Guidelines Established Using a Delphi Approach.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
    Article
  9. Review
  10. Article
  11. Review
  12. Landmark Studies in Differentiated Thyroid Cancer.Annals of surgical oncology · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 12 institutions in 6 countries.

Ralph P TufanoDivision of Otolaryngology - Endocrine Head and Neck Surgery, Johns Hopkins University, Baltimore, MD, United States.
Pia Pace-AsciakDepartment of Otolaryngology - Head and Neck Surgery, University of Toronto, Toronto, ON, Canada.
Jonathon O RussellDivision of Otolaryngology - Endocrine Head and Neck Surgery, Johns Hopkins University, Baltimore, MD, United States.
Carlos SuárezInstituto de Investigación Sanitaria del Principado de Asturias and CIBERONC, ISCIII, Oviedo, Spain.
Gregory W RandolphDivision of Otolaryngology - Endocrine Head and Neck Surgery, Harvard University, Massachusetts Eye and Ear Infirmary, Boston, MA, United States.
Fernando LópezDepartment of Otorhinolaryngology, Head and Neck Surgery, Hospital Universitario Central de Asturias, Oviedo, Spain.
Ashok R ShahaHead and Neck Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, United States.
Antti MäkitieDepartment of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Juan P RodrigoDepartment of Otorhinolaryngology, Head and Neck Surgery, Hospital Universitario Central de Asturias, Oviedo, Spain.
Luiz Paulo KowalskiDepartment of Head and Neck Surgery, University of Sao Paulo Medical School and Department of Head and Neck Surgery and Otorhinolaryngology Department, AC Camargo Cancer Center, Sao Paulo, Brazil.
Mark ZafereoDepartment of Head & Neck Surgery, MD Anderson Cancer Center, Houston, TX, United States.
Peter AngelosDepartment of Surgery, Bucksbaum Institute for Clinical Excellence, University of Chicago, Chicago, IL, United States.
Alfio FerlitoThe University of Udine School of Medicine, International Head and Neck Scientific Group, Padua, Italy.
Hospital Universitario Central de Asturias · ESAC Camargo Hospital · BRHarvard University · USInstituto de Investigación Sanitaria del Principado de Asturias · ESJohns Hopkins Medicine · USJohns Hopkins University · USMemorial Sloan Kettering Cancer Center · USThe University of Texas MD Anderson Cancer Center · USUniversity of Chicago · USUniversity of Helsinki · FIUniversity of Toronto · CAUniversity of Udine · IT

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Thermal and chemical ablation are minimally invasive procedures that avoid removal of the thyroid gland and target symptomatic nodules directly. Internationally, Radiofrequency ablation (RFA) is among one of the most widely used thermal ablative techniques, and is gaining traction in North America. Surgery remains the standard of care for most thyroid cancer, and in the right clinical setting, Active Surveillance (AS) can be a reasonable option for low risk disease. Minimally invasive techniques have emerged as an alternative option for patients deemed high risk for surgery, or for those patients who wish to receive a more active treatment approach compared to AS. Herein, we review the literature on the safety and efficacy of RFA for treating benign non-functioning thyroid nodules, autonomously functioning thyroid nodules, primary small low risk thyroid cancer (namely papillary thyroid cancer) as well as recurrent thyroid cancer.

Indexed as

Catheter AblationHistory, 21st CenturyHumansNeoplasm Recurrence, LocalRadiofrequency AblationThyroid Cancer, PapillaryThyroid NeoplasmsThyroid NoduleTreatment Outcomeautonomously functioning thyroid nodulesbenign thyroid nodulesprimary thyroid cancerradiofrequency ablationrecurrent thyroid cancerthermal ablation

Identifiers

PMID34248853
PMCPMC8264548
OpenAlexW3175496554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.